Fingerprint
Dive into the research topics of 'Benefit of Oxaliplatin in Stage III Colon Cancer According to IDEA Risk Groups: Findings from the ACCENT Database of 4934 Patients'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Benefit of Oxaliplatin in Stage III Colon Cancer According to IDEA Risk Groups: Findings from the ACCENT Database of 4934 Patients
Ofer Margalit, Ben Boursi, Manel Rakez, André Thierry, Greg Yothers, Norman Wolmark, Daniel G. Haller, Hans Joachim Schmoll, Qian Shi, Einat Shacham-Shmueli, Aimery de Gramont
Research output: Contribution to journal › Article › peer-review